OCTOBIDPublic Tender GazetteGlioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Grant monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- Grant
- Solicitation number
- RFA-CA-27-005
- Posted
- August 31, 2026
- Response deadline
- October 1, 2026
- Location
- US
- Estimated value
- $700,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical tria…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.